Back to Rankings

RNAZ

TransCode TherapeuticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
RNAZ vs peer average
48/100
RNAZ vs. peer average (F vs. F)
Grade spread
D 1 · F 6
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

INM is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $5.04M

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerINMInMed
RNAZ
TransCode Therapeutics
INM
InMed
Grade
F
F
Momentum
8
12
Value
41
58
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs INM

RNAZ / INM
Grade Position
In line
RNAZ vs. peer average (F vs. F)
48/100
Momentum
8
INM
Value
41
INM
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs RNAZ
1
INM
InMed Pharmaceuticals Inc Common
F
20/100
Even
2
SPRC
SciSparc Ltd Common
F
20/100
Even
3
ARTL
Artelo Biosciences Inc Common
F
20/100
Even
4
ADIL
Adial Pharmaceuticals Inc Common
F
20/100
Even
5
AQB
AquaBounty Technologies Inc Common
F
20/100
Even
INM is the first peer returned for this comparison set.